Characteristics of disorders of gut-brain interaction in the Japanese population in the Rome Foundation Global Epidemiological Study
- PMID: 37093785
- DOI: 10.1111/nmo.14581
Characteristics of disorders of gut-brain interaction in the Japanese population in the Rome Foundation Global Epidemiological Study
Abstract
Background: The aims were to use Japanese data from the Rome Foundation Global Epidemiological Study (RFGES) to test the hypotheses that severity of gastrointestinal (GI) symptoms and psychosocial disturbance are ordered as Rome IV irritable bowel syndrome (IBS) > Rome III IBS > DGBI, not IBS > others.
Methods: Subjects were 2504 Japanese in the RFGES. We assessed DGBI/IBS diagnoses with Rome IV/III, IBS Symptom Severity Scale (IBS-SSS), Patient Health Questionnaire (PHQ) for anxiety/depression and non-GI somatic symptoms, PROMIS-10 for quality of life (QOL), Work Productivity and Activity Impairment (WPAI) Questionnaire, parts of Self-reported IBS Questionnaire (SIBSQ) for meal effect and stress effect, Food Frequency Questionnaire, and medication questions.
Key results: The prevalence of Rome IV DGBI was as follows; IBS-C 0.5%, IBS-D 0.8%, IBS-M 0.8%, IBS-U 0.1%, unspecified functional bowel disorder 10.7%, postprandial distress syndrome 2.2%, and epigastric pain syndrome 0.3%. Rome III IBS prevalence; IBS-C 3.0%, IBS-D 3.1%, IBS-M 2.7%, and IBS-U 0.6%. Comparison among Rome IV IBS (n = 54), Rome III IBS (n = 197), other DGBI (n = 746), others (n = 1389) revealed significant order as Rome IV IBS > Rome III IBS > other DGBI > others in IBS-SSS, anxiety/depression, activity impairment, non-GI symptoms, physical QOL, mental QOL, exacerbated symptoms by meals and perceived stress (all p < 0.001).
Conclusions & inferences: These findings support the study hypotheses. Data from Japan as a culturally homogenous country suggest Rome IV IBS is more severe and hence has more gut-brain psychobehavioral involvement than Rome III IBS.
Keywords: Japan; epidemiology; food; gut-brain interaction; irritable bowel syndrome; stress.
© 2023 The Authors. Neurogastroenterology & Motility published by John Wiley & Sons Ltd.
Similar articles
-
The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study.Sci Rep. 2023 May 30;13(1):8769. doi: 10.1038/s41598-023-35774-5. Sci Rep. 2023. PMID: 37253969 Free PMC article.
-
Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life.Clin Gastroenterol Hepatol. 2022 May;20(5):e945-e956. doi: 10.1016/j.cgh.2021.05.042. Epub 2021 May 27. Clin Gastroenterol Hepatol. 2022. PMID: 34052391
-
The epidemiology and impact of disorders of gut-brain interaction in Canada: Results from the Rome Foundation Global Epidemiologic Study.Neurogastroenterol Motil. 2023 Jun;35(6):e14585. doi: 10.1111/nmo.14585. Epub 2023 Mar 29. Neurogastroenterol Motil. 2023. PMID: 36989173
-
The Rome Foundation Global Epidemiology study: Conception, implementation, results, and future potential.Neurogastroenterol Motil. 2023 Jun;35(6):e14567. doi: 10.1111/nmo.14567. Epub 2023 Mar 29. Neurogastroenterol Motil. 2023. PMID: 36989175 Review.
-
Review article: epidemiology of IBS and other bowel disorders of gut-brain interaction (DGBI).Aliment Pharmacol Ther. 2021 Dec;54 Suppl 1:S1-S11. doi: 10.1111/apt.16582. Aliment Pharmacol Ther. 2021. PMID: 34927754 Review.
Cited by
-
Association between disturbance of self-organization and irritable bowel syndrome in Japanese population using the international trauma questionnaire.Sci Rep. 2024 Aug 8;14(1):18412. doi: 10.1038/s41598-024-68196-y. Sci Rep. 2024. PMID: 39117720 Free PMC article.
-
Factors Associated With the Prevalence of Irritable Bowel Syndrome: The Miyagi Part of the Tohoku Medical Megabank Project Community-based Cohort Study.J Neurogastroenterol Motil. 2024 Apr 30;30(2):208-219. doi: 10.5056/jnm23090. J Neurogastroenterol Motil. 2024. PMID: 38576370 Free PMC article.
-
Effects of a Protease Inhibitor Camostat Mesilate on Gut Microbial Function in Patients with Irritable Bowel Syndrome: A Pilot Randomized Placebo-Controlled Study.Digestion. 2025;106(4):265-276. doi: 10.1159/000542758. Epub 2024 Nov 25. Digestion. 2025. PMID: 39586243 Free PMC article. Clinical Trial.
-
Psychosocial characteristics of workers with irritable bowel syndrome and its relationship with abdominal symptoms and work productivity.J Occup Health. 2024 Jan 4;66(1):uiae012. doi: 10.1093/joccuh/uiae012. J Occup Health. 2024. PMID: 38443952 Free PMC article.
References
REFERENCES
-
- Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150:1257-1261.
-
- Nguyen NH, Khera R, Ohno-Machado L, Sandborn WJ, Singh S. Annual burden and costs of hospitalization for high-need, high-cost patients with chronic gastrointestinal and liver diseases. Clin Gastroenterol Hepatol. 2018;16:1284-1292. e30.
-
- Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150:1393-1407.
-
- Enck P, Aziz Q, Barbara G, et al. Irritable bowel syndrome (IBS). Nat Rev Dis Primers. 2016;2:16014.
-
- Leong SA, Barghout V, Birnbaum HG, et al. The economic consequences of irritable bowel syndrome: a US employer perspective. Arch Intern Med. 2003;163:929-935.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources